Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease
The Alzheimer's disease (AD) epidemic is a looming crisis, with an urgent need for new therapies to delay or prevent symptom onset and progression. There is growing awareness that clinical trials must target s...